Kenneth I Kaitin to Retire from the Tufts Center for the Study of Drug Development after Leading the Organization for 23 Years
December 08, 2020 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, Dec. 08, 2020 (GLOBE NEWSWIRE) -- The Tufts Center for the Study of Drug Development (CSDD), the leading independent source of authoritative analyses on the nature and pace of pharmaceutical...
Kinnate Biopharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
December 07, 2020 16:05 ET
|
Kinnate Biopharma
SAN FRANCISCO and SAN DIEGO, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small...
Kinnate Biopharma Announces Pricing of Initial Public Offering
December 02, 2020 22:02 ET
|
Kinnate Biopharma
SAN FRANCISCO and SAN DIEGO, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small...
Global Pharmacovigilance Market 2020-2027 - Phase IV Held a Dominant Market Share at 75.56%
November 26, 2020 06:03 ET
|
Research and Markets
Dublin, Nov. 26, 2020 (GLOBE NEWSWIRE) -- The "Pharmacovigilance Market Size, Share & Trends Analysis Report by Product Life Cycle, by Service Provider, by Type, by Therapeutic Area, by Process...
Processa Pharmaceuticals Announces Third Quarter 2020 Results, Provides Corporate Update
November 12, 2020 17:02 ET
|
Processa Pharmaceuticals Inc.
HANOVER, MD., Nov. 12, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) (“Processa” or the “Company”), a clinical-stage biopharmaceutical company focused on...
Transition to Decentralized Clinical Trials during the Coronavirus Pandemic Is far More Nuanced than Expected, According to Tufts Center for the Study of Drug Development
November 12, 2020 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, Nov. 12, 2020 (GLOBE NEWSWIRE) -- The coronavirus pandemic has facilitated rapid adoption of decentralized clinical trial execution, with more than half of all global clinical trials now...
New Therapeutic Protocols Targeting Debilitating Disorders on the Horizon
November 11, 2020 08:30 ET
|
Cybin Inc.
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) -- via InvestorWire — Cybin Inc. (NEO: CYBN) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands...
Global Orphan Drugs Markets, 2019-2020 & 2025 - AI-powered Early Disease Diagnosis and Drug Repurposing will Create New Growth Opportunities
November 09, 2020 04:48 ET
|
Research and Markets
Dublin, Nov. 09, 2020 (GLOBE NEWSWIRE) -- The "New Drug Development for Rare Pediatric Disorders Sustaining High Growth in the Global Orphan Drugs Market, 2019-2025" report has been added to...
Global Preclinical Animal Behavior Market (2020 to 2024) - Featuring Kinder Scientific, Med Associates and Ugo Basile Among Others
November 04, 2020 04:18 ET
|
Research and Markets
Dublin, Nov. 04, 2020 (GLOBE NEWSWIRE) -- The "Global Preclinical Animal Behavior Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The preclinical animal behaviour...
Global Therapeutic Drug Monitoring (TDM) Technologies, Markets & Companies Report 2020: Description of 35 Companies Involved with Their Collaborations in this Area
November 03, 2020 03:33 ET
|
Research and Markets
Dublin, Nov. 03, 2020 (GLOBE NEWSWIRE) -- The "Therapeutic Drug Monitoring - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's...